JTCS Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Frank W. Sellke
John E. Mayer, Jr
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schermerhorn, M. L.
Right arrow Articles by Nelson, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schermerhorn, M. L.
Right arrow Articles by Nelson, D. P.

J Thorac Cardiovasc Surg 2000;120:230-237
© 2000 The American Association for Thoracic Surgery

Surgery for congenital heart disease

Sialyl LewisX oligosaccharide preserves cardiopulmonary and endothelial function after hypothermic circulatory arrest in lambs

Marc L. Schermerhorn, MDa, Motohisa Tofukuji, MD, PhDd, Philip R. Khoury, MSc, Laurie Phillips, PhDe, Paul R. Hickey, MDb, Frank W. Sellke, MDd, John E. Mayer, Jr , MDa, David P. Nelson, MD, PhDc

From the Departments of Cardiovascular Surgerya and Anesthesia,b The Children’s Hospital, Harvard Medical School, Boston, Mass; Division of Pediatric Cardiology, Department of Pediatrics, Children’s Hospital Medical Center, University of Cincinnati School of Medicine,c Cincinnati, Ohio; Division of Cardiothoracic Surgery, Beth Israel Deaconess Hospital, Harvard Medical School,d Boston, Mass; and Cytel Corporation,e San Diego, Calif.

Supported by National Institutes of Health grants RO1 HL46716 and SPO1 HL48675.

Address for reprints: David P. Nelson, MD, PhD, Division of Pediatric Cardiology, Children’s Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH 45229 (E-mail:Davenelson @chmcc.org ).


   Abstract
Top
 Abstract
Introduction
 Material and methods
Results
Discussion
References
 
Objective: Neutrophil adhesion to endothelium contributes to cardiopulmonary dysfunction after cardiac surgical procedures. Initial neutrophil-endothelial interactions involve selectins, which bind carbohydrate ligands, such as sialyl-LewisX. Blockade of selectin-mediated neutrophil interactions with CY1503, a synthetic oligosaccharide analog of sialyl-LewisX, could limit neutrophil-mediated injury after cardiopulmonary bypass.
Methods: The efficacy of CY1503 treatment was tested in a lamb model of cardiopulmonary bypass with hypothermic circulatory arrest. Neonatal lambs received CY1503 (n = 6, CPB-CY1503) or saline solution vehicle (n = 7, CPB-saline) into the pump prime before bypass and as a continuous infusion throughout reperfusion. Five lambs served as control animals for in vitro microvessel studies. Indexes of myocardial function (preload recruitable stroke work index, and rate of pressure rise) and pulmonary function (compliance, airway resistance, and arterial PO 2) were measured before bypass and during reperfusion. The effect of CY1503 on endothelium-dependent vascular reactivity was assessed by means of in vitro pulmonary and coronary microvessel studies.
Results: Myocardial function was depressed after circulatory arrest, but CY1503 preserved function near baseline (36% ± 25% vs 99% ± 19% of baseline at 3 hours of reperfusion). CY1503-treated animals also demonstrated improved pulmonary function during reperfusion. In vitro microvessel analysis of vascular reactivity revealed endothelial dysfunction after circulatory arrest compared with control lambs. CY1503-treated lambs (CPB-CY1503) had intact endothelial function, as demonstrated by normal vasodilatory responses to endothelium-dependent vasodilators.
Conclusions: CY1503 preserves cardiopulmonary and endothelial function after cardiopulmonary bypass and hypothermic circulatory arrest in neonatal lambs. This suggests a role for selectin-mediated, neutrophil-endothelial interactions in the inflammatory response after cardiac operations.


   Introduction
Top
 Abstract
 Introduction
Material and methods
Results
Discussion
References
 
Most reparative cardiac surgical procedures require cardiopulmonary bypass (CPB), which results in an obligatory period of myocardial and pulmonary ischemia with subsequent reperfusion.Go 1 Furthermore, neonatal cardiac operations often necessitate deep hypothermic circulatory arrest (DHCA), which results in whole body ischemia-reperfusion. These planned periods of ischemia-reperfusion can initiate tissue and vascular injury throughout the body, most notably in the heart and lungs.Go 2 Activation of inflammatory cascades by the extracorporeal circuit may also contribute to inflammatory injury after CPB.Go 3

Interactions between leukocytes and vascular endothelium are integral to various inflammatory disorders, including ischemia-reperfusion injury. The inflammatory events after cardiopulmonary support are known to be neutrophil mediated.Go 3 Correspondingly, expression of a variety of leukocyte-endothelial adhesion molecules is upregulated after CPB.Go Go 4,5 Neutrophil-endothelial interactions are a multistep process whereby adhesion molecules on both leukocytes and vascular endothelium mediate the initial rolling and subsequent firm adhesion of leukocytes to endothelial cells.Go 6 The initial rolling of leukocytes along the endothelial surface is mediated by the selectins (P-, E-, and L-selectin), which recognize fucosylated carbohydrate ligands on the neutrophil, such as sialyl Lewisx antigen. The rolling of leukocytes, which occurs at the onset of inflammation, is a prerequisite for firm leukocyte adhesion and transendothelial leukocyte migration.Go 6

Prevention of leukocyte adhesion to the endothelium may be a potential strategy to reduce the inflammation-related morbidity of CPB by preventing reperfusion injury to the heart, lungs, and other organs. Inhibition of the initial selectin-mediated leukocyte-endothelial interactions is intuitively attractive. In blood-perfused isolated lamb hearts subjected to 2 hours of hypothermic ischemia followed by reperfusion, we have demonstrated preservation of myocardial contractile function by selectin blockade with either fucoidinGo 7 or the synthetic sialyl Lewisx analog CY1503 (unpublished data). In other animal models of inflammation or ischemic injury, administration of CY1503 has been shown to be effective in reducing neutrophil accumulation and tissue injury, including myocardial infarction,Go Go 8-11 acute lung injury,Go Go 12-14 trauma,Go 15 transplantation,Go Go 12,16 and septic shock.Go 13 Animal models of myocardial infarction have demonstrated that CY1503 treatment before reperfusion reduces infarct size, preserves contractile function, and maintains normal coronary vascular reactivity.Go Go 8-10 In a similar manner we reasoned that administration of CY1503 might limit the inflammatory tissue injury related to CPB with DHCA (CPB-DHCA). Because circulatory support is commonly associated with alterations in myocardial performance, pulmonary function, and vascular reactivity postoperatively, the present study was undertaken to determine whether administration of CY1503 could preserve myocardial, pulmonary, and vascular endothelial function in a neonatal lamb model of CPB and circulatory arrest.


   Material and methods
Top
 Abstract
 Introduction
 Material and methods
Results
Discussion
References
 
Experimental preparation
Neonatal lambs (age, 5-7 days; weight, 5-8 kg) were anesthetized with intramuscular ketamine (40 mg/kg) and intubated. Mechanical ventilation was instituted with a Servo 900C ventilator (Siemens, Danvers, Mass) with tidal volumes of 15 mL/kg, a fraction of inspired oxygen of 1.0, and 3 cm H2O positive end-expiratory pressure. The respiratory rate was adjusted to maintain PCO 2 between 35 and 45 mm Hg. After venous access had been established, an induction dose of fentanyl (300 µg/kg) was given, and continuous infusions of fentanyl (50 µg · kg–1 · h–1), ketamine (5 mg · kg–1 · h–1), and midazolam (0.5 mg · kg–1 · h–1) were begun and given throughout the remainder of the experiment, excluding the circulatory arrest period. Catheters were placed in the femoral artery and vein, the left atrium, and the main pulmonary artery for hemodynamic measurements and blood sampling. Sonomicrometry crystals were placed on the epicardium of the left ventricular free wall along the equatorial circumference for measurement of myocardial segmental shortening.Go 17 After systemic heparinization (400 U/kg), a 5F vascular sheath was inserted into the left ventricle through the apex for pressure measurement with a pressure transducer (SPC-350; Millar Instruments, Inc, Houston, Tex) and for venting during CPB. The extracorporeal bypass circuit consisted of a standard roller pump (Cardiovascular Instruments, Wakefield, Mass), sterile new membrane oxygenator (VPCML, Cobe Laboratories Inc, Lakewood, Colo), and sterile new tubing. The pump prime consisted of 200 mL of Normosol solution and 500 mL of homologous donor blood (hematocrit value, ~20%) warmed to 37°C.

Experimental procedure
After baseline ventricular and pulmonary function measurements had been recorded, CPB was instituted at 150 mL · kg–1 · min–1 through an 8F arterial cannula placed in the right femoral artery and a 24F venous cannula placed in the right atrium. After 5 minutes of normothermic CPB, phentolamine hydrochloride (0.2 mg/kg) was given, systemic cooling was begun, and the esophageal temperature was lowered to 15°C over 25 minutes by the pH-stat blood gas strategy. A 2-hour period of hypothermic circulatory arrest followed, with additional topical cooling of the heart with saline solution at 4°C. CPB was reinitiated after 2 hours of circulatory arrest, and the animals were rewarmed to an esophageal temperature of 35°C over 30 minutes. Spontaneous return of sinus rhythm occurred in all animals, thus allowing the animals to be separated from CPB after the 30-minute rewarming period. The animals’ lungs were not ventilated during CPB or circulatory arrest. During the subsequent 3-hour reperfusion period after termination of CPB, the animals’ lungs were ventilated and the animals did not receive inotropic support. Myocardial and pulmonary function measurements were repeated at 1, 2, and 3 hours of reperfusion.

Myocardial function: Preload recruitable stroke work index
Preload recruitable stroke work index (PRSWI), a load-independent measure of cardiac function, was measured during transient inferior vena caval occlusion.Go 17 Left ventricular pressure (Millar transducer) and segment length (sonomicrometry crystals) were measured simultaneously during successive cardiac cycles to generate pressure-segment length loops; each loop represents the regional myocardial stroke work of a specific cardiac cycle. During caval occlusion, a series of pressure-segment length loops were generated as preload decreased decrementally. Regional myocardial stroke work is linearly related to end-diastolic segment length, and the slope of the regression of this relationship determines the PRSWI. PRSW was determined at baseline (before hypothermic circulatory arrest) and at 1, 2, and 3 hours of reperfusion. Each determination represented an average of 3 caval occlusions, and regressions were excellent in all animals (r 2 >= 0.98).

Pulmonary function
The lambs’ lungs were ventilated with a Servo 900C ventilator (Siemens) with tidal volumes of 15 mL/kg, a fraction of inspired oxygen of 1.0, and 3 cm H2O positive end-expiratory pressure. To set a consistent lung volume history, lungs were inflated to a sustained static inflation pressure of 40 cm H2O for 30 seconds immediately before measurements. Pulmonary mechanics were measured with the integrated pulmonary mechanics module for the Servo 900C ventilator (Siemens). Dynamic pulmonary compliance was determined as expired tidal volume divided by change in pressure (end-inspiratory pressure – positive end-expiratory pressure). Passive expiratory airway resistance was determined as change in pressure (end-inspiratory pressure – positive end-expiratory pressure) divided by peak expiratory flow. Pulmonary function and simultaneous arterial blood gas measurements were made at baseline (before CPB) and 1, 2, and 3 hours of reperfusion.

Edema formation
Samples of the left ventricle, lung, kidney, and liver were harvested after 3 hours of reperfusion. Tissue samples were weighed, desiccated in an oven for 48 hours, and reweighed. Wet/dry weight ratios were calculated and expressed as means ± SD.

In vitro microvessel studies
Pulmonary arterioles (75-200 µm) were dissected from the lungs of sheep by means of a 10-60x dissecting microscope (Olympus Optical Co, Ltd, Tokyo, Japan). In a similar manner, coronary arterial microvessels (75-200 µm in internal diameter) were dissected from the subepicardial region of the left ventricle of each heart. Tissue samples were immediately placed in cold (~4°C) Krebs buffer solution. Microvessels were placed in a Plexiglas organ chamber (Rohm and Haas Company, Philadelphia, Pa), cannulated with dual glass micropipettes measuring 30 to 80 µm in diameter, and secured with 10-0 nylon monofilament suture (Ethicon, Inc, Somerville, NJ). 3-(N-morpholino) propanesulfonic acid (MOPS) buffer solution warmed to 37°C was continuously circulated through the organ chamber and a reservoir (total fluid volume, 100 mL). Pulmonary microvessels were pressurized to 20 mm Hg, and coronary microvessels were pressurized to 40 mm Hg in a no-flow state by using a burette manometer filled with MOPS buffer solution. MOPS buffer solution was composed of the following: NaCl, 145.0 mmol/L; KCl, 4.7 mmol/L; CaCl2, 2.0 mmol/L; MgSO4, 1.2 mmol/L; glucose, 5.0 mmol/L; pyruvate, 2.0 mmol/L; ethylenediaminetetraacetic acid, 0.02 mmol/L; NaH2PO4, 1.2 mmol/L; and MOPS, 3.0 mmol/L.

An inverted microscope (40-200x; Olympus) was connected to a video camera, and the vessel image was projected onto a black-and-white television monitor (Hitachi Ltd, Tokyo, Japan). An electronic dimension analyzer (Living System Instrumentation, Burlington, Vt) was used to measure the internal lumen diameter. Measurements were recorded with a strip-chart recorder. Vessels were allowed to equilibrate for at least 30 minutes in Krebs buffer solution before a drug intervention.

Relaxation responses of pulmonary and coronary microvessels were examined after precontraction of vessels by 20% to 60% with the thromboxane A2 analog U46619. Once the steady-state tone was attained, the dose responses to acetylcholine (10–9-10–4 mol/L) and sodium nitroprusside (10–9-10–4 mol/L) were examined in pulmonary vessels, and the responses to the calcium ionophore A23187 (10–9-10–5 mol/L) and sodium nitroprusside (10–9-10–4 mol/L) were examined in coronary vessels. Acetylcholine was observed to cause contraction of sheep coronary microvessels and was therefore not used to assess endothelium-dependent relaxation. Drugs were applied extraluminally. Measurements were always taken 2 to 3 minutes after the drug was administered, when the response had stabilized. The vessels were washed 3 times with MOPS buffer solution and allowed to equilibrate in a drug-free buffer solution for 10 to 15 minutes between pharmacologic interventions.

Drugs
Acetylcholine chloride, A23187, U46619, MOPS, and sodium nitroprusside were obtained from Sigma Chemical Company (St Louis, Mo). U46619 was dissolved in ethanol and water. Other drugs were dissolved in ultrapure distilled water. All solutions were prepared on the day of the study.

Experimental groups
The sialyl Lewisx analog (CY1503) used in this study was provided by Cytel Corporation (San Diego, Calif). Animals in the experimental group (CPB-CY1503, n = 6) received CY1503 (20 mg/kg) added to the pump prime before institution of CPB and a continuous infusion (3.33 mg · kg–1 · h–1) during reperfusion to attain constant levels of CY1503 before ischemia and during the entire period of reperfusion. Control animals (CPB-saline, n = 7) received saline vehicle alone. Control animals for in vitro microvessel studies were anesthetized, intubated, ventilated, and received a sham sternotomy, after which peripheral segments of lung and myocardial samples for microvessel analysis were harvested.

Data analysis
Results from myocardial and pulmonary function measurements are expressed as percentage recovery of baseline (mean ± SD). Differences between groups were determined by repeated-measures analysis of variance.

The response of microvessels to each agent or pressure intervention was examined once in each animal. Dose-response data from each experimental group were pooled. Differences between groups were determined by using 2-factor repeated-measures analysis of variance and the Scheffé test post hoc. Values are expressed as means ± SEM.

Animals in this study received humane care in compliance with the "Principles of Laboratory Animal Care" formulated by the National Society for Medical Research and the "Guide for the Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and published by the National Institutes of Health (National Institutes of Health publication No. 85-23, revised in 1985).


   Results
Top
 Abstract
 Introduction
 Material and methods
Results
Discussion
References
 
Myocardial function and hemodynamics
There were no baseline differences in the measured indices of myocardial function between the two groups (Table I). Fig 1 displays the percentage recovery of myocardial function (PRSWI and rate of pressure rise [+dP/dt] and fall [–dP/dt]) at 1, 2, and 3 hours’ reperfusion after CPB-DHCA. Myocardial function was markedly depressed throughout the 3-hour reperfusion period in untreated lambs subjected to 2 hours of DHCA. Myocardial function was significantly preserved in CY1503-treated animals; recovery of PRSWI, +dP/dt, and –dP/dt was better in the CY1503-treated lambs than in the untreated control animals (P = .001, .04, and .01, respectively). The improvement in myocardial function corresponded to greater systolic and mean arterial pressure in CY1503-treated animals, with no difference in left atrial pressure between groups (Table II).


View this table:
[in this window]
[in a new window]
  		Table I. Baseline myocardial and pulmonary function measurements
 


View larger version (20K):
[in this window]
[in a new window]
  		Fig. 1. Myocardial contractile function in control and CY1503-treated animals during reperfusion. The upper panel demonstrates that PRSWI (a load-independent measure of contractile function) is greater in Cy1503-treated animals throughout reperfusion (P = .001, overall difference between groups determined by repeated-measures analysis of variance). The lower panels show that +dP/dt and –dP/dt (load-dependent measures of myocardial function) are greater in CY1503-treated animals throughout reperfusion (P = .04 and .01, respectively). Results are expressed as the percentage recovery of baseline value (mean ± SD).

 

View this table:
[in this window]
[in a new window]
  		Table II. Hemodynamics and PaO 2
 
Pulmonary function
Pulmonary mechanics were not significantly impaired after CBP-DHCA (Fig 2); dynamic lung compliance and airways resistance approached baseline values in untreated animals during reperfusion. In spite of this, animals treated with CY1503 exhibited slightly better dynamic lung compliance and expiratory airway resistance than did untreated animals (repeated-measures analysis of variance revealed overall differences between groups: P = .014 and .037, respectively). Pulmonary gas exchange was mildly impaired in the untreated lambs after CPB, as demonstrated by the progressive fall in arterial PO 2 (PaO 2) during reperfusion. Gas exchange was better preserved in CY1503-treated animals, as demonstrated by higher PaO 2 throughout reperfusion (Table IIGo).



View larger version (25K):
[in this window]
[in a new window]
  		Fig. 2. Pulmonary function in control and CY1503-treated animals during reperfusion. Although pulmonary mechanics are not markedly impaired after CBP-DHCA, dynamic lung compliance and expiratory airway resistance are slightly better in CY1503-treated animals throughout reperfusion (P = .014 and .037, respectively; overall difference between groups determined by repeated-measures analysis of variance). Results are expressed as the percentage recovery of baseline value (mean ± SD).

 
Wet/dry weight ratio
No differences were noted in wet/dry weight ratios of heart, lung, liver, or kidney between the untreated and CY1503-treated groups (Table III).


View this table:
[in this window]
[in a new window]
  		Table III. Wet/dry weight ratios
 
Vessel characteristics
Pulmonary microvessels averaged 160 ± 9 µm, 149 ± 10 µm, and 160 ± 10 µm in the control, CPB-saline, and CPB-CY1503 groups, respectively. The percentage of precontraction after application of U46619 was 45% ± 6%, 47% ± 5%, and 45% ± 3% in the control, CPB-saline, and CPB-1503 groups, respectively. Coronary microvessels averaged 181 ± 7 µm, 164 ± 9 µm, and 186 ± 6 µm in the control, CPB-saline, and CPB-CY1503 groups, respectively. The percentage of precontraction after application of U46619 was 38% ± 2%, 42% ± 2%, and 45% ± 4% in the control, CPB-saline, and CPB-CY1503 groups, respectively.

Pulmonary vascular responses
Pulmonary endothelium–dependent microvascular relaxation to acetylcholine was impaired after CPB compared with the control response, whereas vessels from CY1503-treated animals showed normal relaxation to acetylcholine (Fig 3, A ). Endothelium-independent relaxation to sodium nitroprusside was similar in all groups (Fig 3Go, B ).



View larger version (15K):
[in this window]
[in a new window]
  		Fig. 3. In vitro dose responses of pulmonary microvessels to the endothelium-dependent and endothelium-independent agonists acetylcholine (A) and sodium nitroprusside (B) in control, CPB-saline, and CPB-CY1503 groups (displayed as log to the base 10 of the specific vasodilator). Vessels were precontracted with U46619, and responses are given as percentage relaxation of U46619-induced vessel contraction. CPB with circulatory arrest resulted in significant pulmonary endothelial dysfunction, which was prevented by CY1503 treatment. Asterisks indicate overall difference in dose response of the control and CPB-CY1503 groups compared with the CPB-saline group, as determined by repeated-measures analysis of variance and the Scheffé test post hoc (P < .01).

 
Coronary vascular responses
Coronary endothelium–dependent microvascular relaxation to the calcium ionophore A23187 was reduced after CPB compared with the control response, whereas vessels from CY1503-treated animals showed normal relaxation to A23187 (Fig 4, A ). Endothelium-independent relaxation to sodium nitroprusside was similar in all groups (Fig 4Go, B ).



View larger version (15K):
[in this window]
[in a new window]
  		Fig. 4. In vitro dose-responses of coronary microvessels to the endothelium-dependent and endothelium-independent agonists A23187 (A) and sodium nitroprusside (B) in the control, CPB-saline, and CPB-CY1503 groups (displayed as log to the base 10 of the specific vasodilator). Vessels were precontracted with U46619, and responses are given as percentage relaxation of U46619-induced vessel contraction. CPB with circulatory arrest resulted in significant coronary endothelial dysfunction, which was prevented by CY1503 treatment. Asterisks indicate overall difference in dose response of the control and CPB-CY1503 groups compared with the CPB-saline group, as determined by repeated-measures analysis of variance and the Scheffé test post hoc (P < .01).

 

   Discussion
Top
 Abstract
 Introduction
 Material and methods
Results
Discussion
References
 
Ischemia-reperfusion injury is a complex process that occurs in multiple pathologic states, including cardiovascular operations, transplantation, trauma, stroke, and myocardial infarction.Go 2 CPB is a particularly potent stimulus for inflammatory injury; activation of blood components by the extracorporeal circuit may augment tissue reperfusion injury.Go Go 1,3 The inflammatory process resulting from ischemia with subsequent reperfusion involves (1) neutrophil recruitment and activation and (2) release of proinflammatory cytokines, toxic oxygen metabolites, and proteases.Go 6 Interactions between neutrophils and endothelium are integral to the deleterious inflammatory process.Go 6 The initial tethering of neutrophils to endothelium is mediated by the selectins, glycoprotein endothelial adhesion molecules that bind to oligosaccharide ligands on neutrophils, including sialyl Lewisx.Go 18 P-selectin is stored preformed in endothelial Weibel-Palade bodies, and surface expression can occur within minutes in response to histamine, thrombin, complement, and hypoxia. By contrast, E-selectin is synthesized de novo in response to cytokines, such as interleukin 8, interleukin 1, lipopolysaccharide, and tumor necrosis factor {alpha}; maximal expression occurs within 4 to 6 hours and persists for 24 to 48 hours. After the initial step of selectin-mediated leukocyte rolling, firm adhesion between neutrophils and endothelial cells occurs through interaction of integrins and intercellular adhesion molecules, bringing activated neutrophils into intimate contact with the endothelial surface to allow local damage to endothelium and transendothelial migration into parenchymal tissue.Go 6

Interruption of neutrophil-endothelial adhesion offers the potential to abort or diminish the inflammatory process with obvious therapeutic potential. Antibodies to various adhesion molecules have protective effects after myocardial ischemia-reperfusion. Monoclonal antibodies to CD11 and CD18 reduce myocardial and endothelial damage after global or focal ischemia.Go Go 19-21 Monoclonal antibodies directed against P-selectin,Go 22 L-selectin,Go 23 and intercellular adhesion molecule 1Go 24 have been shown to improve recovery of contractile and endothelial function and decrease neutrophil accumulation after temporary coronary ligation in feline or canine hearts.

We reasoned that blockade of selectin-mediated neutrophil-endothelial interactions could prevent inflammatory tissue injury after CPB and hypothermic circulatory arrest. CY1503, a synthetic oligosaccharide analog of sialyl Lewisx, is thought to reduce neutrophil adherence to endothelium by saturation blockade of selectins. CY1503 has been shown to reduce tissue injury in multiple animal models of ischemia-reperfusion,Go Go 8-16 and the present data provide further evidence of the protective effects of CY1503 in another animal model. Pulmonary and coronary endothelial dysfunction, as normally accompanies CPB, was absent in CY1503-treated lambs subjected to CPB and circulatory arrest. This finding correlated with significant preservation of myocardial contractile and pulmonary function in the CPB-CY1503 group. Although the data suggest that preservation of myocardial and pulmonary function results from selectin blockade, other potential mechanisms of protection cannot be ruled out. The data are consistent with observations made in CY1503-treated pigs undergoing CPB,Go 25 but cardiopulmonary and endothelial preservation associated with CY1503 treatment was more dramatic in the neonatal lambs we studied. The greater efficacy of CY1503 in neonatal lambs may be an age- or species-dependent effect. Alternatively, CY1503 was given in the present study before CPB-DHCA and continuously during reperfusion, whereas in the previous study it was given as a 1-time bolus before aortic crossclamp removal. It seems likely that microvascular distribution of CY1503 is more homogeneous when given before ischemia, and maintaining continuous levels of the oligosaccharide during reperfusion may also be necessary for optimal efficacy. Our findings are also consistent with those of multiple animal myocardial infarction studies, which have demonstrated that CY1503 treatment before reperfusion reduces infarct size and neutrophil accumulation while improving cardiac contractility and endothelium-dependent vasodilation.Go Go 8-11 Similarly, CY1503 has also been shown to reduce tissue injury in animal models of acute lung injury,Go Go 12-14 trauma,Go 15 transplantation,Go Go 12,16 and septic shock.Go 13

Preservation of endothelial function by CY1503 is a significant observation of this study. The endothelium appears to be an early target of the reperfusion-related inflammatory process, and endothelial dysfunction occurs early after ischemia-reperfusion.Go Go Go 10,26,27 Regional and global myocardial ischemia-reperfusion impairs endothelium-dependent vasoreactivity and increases capillary permeability.Go Go Go 10,22,28 Endothelial injury during reperfusion may precede damage to the myocardium, and interventions that preserve endothelial function have been associated with improved myocardial contractile function.Go Go 28,29 It is unclear in these studies whether preservation of endothelial function is causative or correlative, but the results of Tofukuji and colleaguesGo 25 might suggest the latter. Endothelial dysfunction and concomitant alterations in vascular reactivity are widely known sequelae of CPB,Go Go 26,30 and preservation of endothelial function in lambs receiving CY1503 is thus notable.

In conclusion, the present study demonstrates the potential utility of antiadhesion therapy in neonatal animals subjected to CPB with DHCA. Our findings suggest that selectin-mediated neutrophil-endothelial interactions play an important role in cardiopulmonary and endothelial dysfunction after DHCA in neonatal lambs. Blockade of the inflammatory process by agents that interfere with leukocyte-endothelial interactions may help optimize organ preservation during cardiac operations.


   References
Top
 Abstract
 Introduction
 Material and methods
Results
Discussion
References
 

  1. Edmonds LH Jr. Inflammatory and immunological response to cardiopulmonary bypass. In: Jonas RA, Elliot MJ, editors. Cardiopulmonary bypass in neonates, infants and young children. Oxford: Butterworth-Heineman; 1994. p. 225-41.
  2. Entman ML, Smith CW. Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc Res 1994;28:1301-11. [Free Full Text]
  3. Hall RI, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 1997;85:766-82. [Medline]
  4. Burns SA, Newburger JW, Xiao M, Mayer JE Jr, Walsh AZ, Neufeld EJ. Induction of interleukin-8 messenger RNA in heart and skeletal muscle during pediatric cardiopulmonary bypass. Circulation 1995;92(Suppl):II-315-21.
  5. Kilbridge PM, Mayer JE, Newburger JW, Hickey PR, Walsh AZ, Neufeld EJ. Induction of intercellular adhesion molecule-1 and E-selectin mRNA in heart and skeletal muscle of pediatric patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;107:1183-92. [Abstract/Free Full Text]
  6. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-14. [Medline]
  7. Miura T, Nelson DP, Schermerhorn ML, Shin’oka T, Zund G, Hickey PR, et al. Blockade of selectin-mediated leukocyte adhesion improves postischemic function in lamb hearts. Ann Thorac Surg 1996;62:1295-300. [Abstract/Free Full Text]
  8. Lefer DJ, Flynn DM, Phillips ML, Ratcliffe M, Buda AJ. A novel sialyl LewisX analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion. Circulation 1994;90:2390-401. [Abstract/Free Full Text]
  9. Silver MJ, Sutton JM, Hook S, Lee P, Malycky JL, Phillips ML, et al. Adjunctive selectin blockade successfully reduces infarct size beyond thrombolysis in the electrolytic canine coronary artery model. Circulation 1995;92:492-9. [Abstract/Free Full Text]
  10. Buerke M, Weyrich AS, Zheng Z, Gaeta FC, Forrest MJ, Lefer AM. Sialyl Lewisx-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J Clin Invest 1994;93:1140-8.
  11. Ueyama T, Ikeda H, Haramaki N, Kuwano K, Imaizumi T. Effects of monoclonal antibody to P-selectin and analogue of sialyl Lewis X on cyclic flow variations in stenosed and endothelium-injured canine coronary arteries. Circulation 1997;95:1554-9. [Abstract/Free Full Text]
  12. Brandt M, Boeke K, Phillips ML, Steinhoff G, Haverich A. Effect of oligosaccharides on rejection and reperfusion injury after lung transplantation. J Heart Lung Transplant 1997;16:352-9. [Medline]
  13. Ridings PC, Holloway S, Bloomfield GL, Phillips ML, Fisher BJ, Blocher CR, et al. Protective role of synthetic sialylated oligosaccharide in sepsis-induced acute lung injury. J Appl Physiol 1997;82:644-51. [Abstract/Free Full Text]
  14. Mulligan MS, Paulson JC, De Frees S, Zheng ZL, Lowe JB, Ward PA. Protective effects of oligosaccharides in P-selectin–dependent lung injury. Nature 1993;364:149-51. [Medline]
  15. Han KT, Sharar SR, Phillips ML, Harlan JM, Winn RK. Sialyl Lewis(x) oligosaccharide reduces ischemia-reperfusion injury in the rabbit ear. J Immunol 1995;155:4011-5. [Abstract]
  16. Yamazaki S, Isobe M, Suzuki J, Tojo S, Horie S, Okubo Y, Sekiguchi M. Role of selectin-dependent adhesion in cardiac allograft rejection. J Heart Lung Transplant 1998;17:1007-16. [Medline]
  17. Glower DD, Spratt JA, Snow ND, Kabas JS, Davis JW, Olsen CO, et al. Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation 1985;71:994-1009. [Abstract/Free Full Text]
  18. Bevilacqua MP, Nelson RM. Selectins. J Clin Invest 1993;91:379-87.
  19. Ma XL, Tsao PS, Lefer AM. Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest 1991;88:1237-43.
  20. Forbess JM, Hiramatsu T, Nomura F, Miura T, Farrington GK, Sokolowski K, et al. Anti-CD11b monoclonal antibody improves myocardial function after six hours of hypothermic storage. Ann Thorac Surg 1995;60:1238-44. [Abstract/Free Full Text]
  21. Simpson P, Todd R, Fantone J, Mickelson J, Griffin J, Lucchesi B. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest 1988;81:624-9.
  22. Weyrich AS, Ma XY, Lefer DJ, Albertine KH, Lefer AM. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993;91:2620-9.
  23. Ma XL, Weyrich AS, Lefer DJ, Buerke M, Albertine KH, Kishimoto TK, et al. Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium. Circulation 1993;88:649-58. [Abstract/Free Full Text]
  24. Ma XL, Lefer DJ, Lefer AM, Rothlein R. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 1992;86:937-46. [Abstract/Free Full Text]
  25. Tofukuji M, Metais C, Collard CD, Morse DS, Stahl GL, Nelson DP, et al. Effect of sialyl Lewis(x) oligosaccharide on myocardial and cerebral injury in the pig. Ann Thorac Surg 1999;67:112-9. [Abstract/Free Full Text]
  26. Sellke FW, Tofukuji M, Stamler A, Li J, Wang SY. Beta-adrenergic regulation of the cerebral microcirculation after hypothermic cardiopulmonary bypass. Circulation 1997;96(Suppl):II-304-10.
  27. Davenpeck KL, Guo JP, Lefer AM. Pulmonary artery endothelial dysfunction following ischemia and reperfusion of the rabbit lung. J Vasc Res 1993;30:145-53. [Medline]
  28. Kawata H, Aoki M, Mayer JE Jr. Nitroglycerin improves functional recovery of neonatal lamb hearts after 2 hours of cold ischemia. Circulation 1993;88(Suppl):II-366-71.
  29. Hiramatsu T, Forbess J, Miura T, Roth SJ, Cioffi MA, Mayer JE Jr. Effects of endothelin-1 and endothelin-A receptor antagonist on recovery after hypothermic cardioplegic ischemia in neonatal lamb hearts. Circulation 1995;92(Suppl):II-400-4.
  30. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993;88:2128-38. [Abstract/Free Full Text]
Received for publication Oct 20, 1999. Revisions requested Dec 16, 1999; revisions received March 10, 2000. Accepted for publication March 15, 2000.


This article has been cited by other articles:


Home page
 PerfusionHome page
H. Komai, Y. Naito, and Y. Okamura
Dextran sulfate as a leukocyte-endothelium adhesion molecule inhibitor of lung injury in pediatric open-heart surgery
Perfusion, March 1, 2005; 20(2): 77 - 82.
[Abstract] [PDF]

Home page
 CirculationHome page
V. A. Schroeder, J. M. Pearl, S. M. Schwartz, T. P. Shanley, P. B. Manning, and D. P. Nelson
Combined Steroid Treatment for Congenital Heart Surgery Improves Oxygen Delivery and Reduces Postbypass Inflammatory Mediator Expression
Circulation, June 10, 2003; 107(22): 2823 - 2828.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
D. P. Nelson, S. Burns Wechsler, T. Miura, A. Stagg, J. W. Newburger, J. E. Mayer Jr, and E. J. Neufeld
Myocardial immediate early gene activation after cardiopulmonary bypass with cardiac ischemia-reperfusion
Ann. Thorac. Surg., January 1, 2002; 73(1): 156 - 162.
[Abstract] [Full Text] [PDF]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
M. P Vallely, P. G Bannon, C. F Hughes, and L. Kritharides
Endothelial Cell Adhesion Molecules and Cardiopulmonary Bypass
Asian Cardiovasc Thorac Ann, December 1, 2001; 9(4): 349 - 355.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Frank W. Sellke
John E. Mayer, Jr
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schermerhorn, M. L.
Right arrow Articles by Nelson, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schermerhorn, M. L.
Right arrow Articles by Nelson, D. P.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS